Saturday, 11 May 2024
Beyondspring Inc. Ordinary Shares
NASDAQ : BYSI
0.8603 14 Oct 22 00:00 | Change: 0.07 | Open: 0.9150 | High: 0.9500 | Ask: 0.0000 | Volume: 81,000 |
Change(%): 7.18 | Prev: 0.9268 | Low: 0.8200 | Bid: 0.0000 | Avg vol: 0 |
01:56 | 18/1/18
GlobeNewswire
NEW YORK, Jan. 17, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that the Company will present ...
more»
01:56 | 6/1/18
GlobeNewswire
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development and commercialization of a pipeline of innovative immuno-oncology ...
more»
03:26 | 6/12/17
StreetInsider.com
Seaport Global Securities initiates coverage on BeyondSpring Inc. (NASDAQ: BYSI) with a Buy rating and a price target of $56.00.
more»
06:37 | 5/12/17
The Ledger Gazette
A hedge fund recently bought a new stake in BeyondSpring stock. Tanaka Capital Management Inc. bought a new stake in shares of BeyondSpring Inc. (NASDAQ:BYSI) in the second quarter, according to the company in its most recent Form 13F filing with the ...
more»
01:00 | 5/12/17
GlobeNewswire
NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that China has recognized the ...
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |